Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.61 and last traded at $5.67, with a volume of 81890 shares changing hands. The stock had previously closed at $5.95. Wall Street Analysts Forecast Growth A number of research analysts have […]
Acelyrin, Inc to Post Q1 2024 Earnings of ($0 86) Per Share, HC Wainwright Forecasts (NASDAQ:SLRN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Acelyrin (NASDAQ:SLRN – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $28.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 328.13% from the company’s previous […]
Conejo Valley-based Acelyrin, a clinical, pre-revenue biotechnology company, reported its financial results for the full year 2023 on March 28. According to the March 28 report, the company’s net loss for the full year ended Dec. 31 was $381.6 million, compared to $64.8 million for 2022. The company primarily saw expenses increase in research and
Acelyrin, Inc (NASDAQ:SLRN) Given Average Recommendation of Moderate Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.